A novel histopathological grading system for ganglioglioma

Area of Science:

• Neuropathology
• Oncology

Background:

• Gangliogliomas are central nervous system tumors often found in young patients' temporal lobes, frequently linked to epilepsy.
• Current classification may not fully capture prognostic variability.

Purpose of the Study:

• To develop and validate a novel histopathological grading system for gangliogliomas.
• To correlate histopathological features with tumor grade, survival, and recurrence.

Main Methods:

• Retrospective analysis of 2011-2020 ganglioglioma cases.
• Evaluation of histopathological criteria including glial mitoses, cellularity, necrosis, and pleomorphism.
• Development of a scoring system to classify tumors as benign, atypical, or anaplastic.

Main Results:

• The proposed grading system successfully stratified gangliogliomas into three tiers with distinct survival rates (90% benign, 71.43% atypical, 62.54% anaplastic).
• Malignant transformation and recurrence rates were documented.
• Specific features like rare glial mitoses and hypercellularity correlated with mortality in atypical gangliogliomas.

Conclusions:

• This histopathological scoring system offers a reliable method for grading gangliogliomas.
• It can identify aggressive tumors requiring close monitoring and potentially guide treatment decisions.
• The system can be adapted into a two-tier model distinguishing low-grade from high-grade tumors.